Loading...
ImmunoPrecise Antibodies Ltd.
IPA•NASDAQ
Healthcare
Biotechnology
$0.95
$0.10(11.33%)
ImmunoPrecise Antibodies Ltd. (IPA) Financial Performance & Statements
Review ImmunoPrecise Antibodies Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
18.65%
↑ 18.65%
Operating Income Growth
47.25%
↑ 47.25%
Net Income Growth
-2.32%
↓ 2.32%
Operating Cash Flow Growth
78.59%
↑ 78.59%
Operating Margin
-55.44%
↓ 55.44%
Gross Margin
50.82%
↑ 50.82%
Net Profit Margin
-192.17%
↓ 192.17%
ROE
-148.08%
↓ 148.08%
ROIC
-36.35%
↓ 36.35%
ImmunoPrecise Antibodies Ltd. (IPA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for ImmunoPrecise Antibodies Ltd. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $6.13M | $5.26M | $6.46M | $6.22M |
| Cost of Revenue | $2.69M | $2.91M | $3.35M | $3.02M |
| Gross Profit | $3.44M | $2.36M | $3.11M | $3.20M |
| Gross Profit Ratio | $0.56 | $0.45 | $0.48 | $0.51 |
| R&D Expenses | $1.16M | $1.64M | $927000.00 | $1.001M |
| SG&A Expenses | $4.51M | $4.88M | $5.03M | $4.83M |
| Operating Expenses | $5.67M | $2.36M | $6.62M | $6.54M |
| Total Costs & Expenses | $8.35M | $9.20M | $9.97M | $9.56M |
| Interest Income | $0.00 | $0.00 | $0.00 | $3000.00 |
| Interest Expense | $120000.00 | $2000.00 | $355000.00 | $5000.00 |
| Depreciation & Amortization | $1.41M | $1.40M | $1.58M | $1.31M |
| EBITDA | -$1.44M | -$3.38M | -$2.27M | -$2.14M |
| EBITDA Ratio | -$0.23 | -$0.64 | -$0.35 | -$0.33 |
| Operating Income | -$2.23M | -$3.93M | -$3.85M | -$3.34M |
| Operating Income Ratio | -$0.36 | -$0.75 | -$0.60 | -$0.54 |
| Other Income/Expenses (Net) | -$831000.00 | -$843000.00 | -$15.31M | -$117000.00 |
| Income Before Tax | -$3.06M | -$4.78M | -$18.82M | -$3.46M |
| Income Before Tax Ratio | -$0.50 | -$0.91 | -$2.91 | -$0.56 |
| Income Tax Expense | -$506000.00 | -$776000.00 | -$777000.00 | -$517000.00 |
| Net Income | -$2.55M | -$4.00M | -$18.05M | -$2.94M |
| Net Income Ratio | -$0.42 | -$0.76 | -$2.79 | -$0.47 |
| EPS | -$0.09 | -$0.15 | -$0.67 | -$0.11 |
| Diluted EPS | -$0.09 | -$0.15 | -$0.67 | -$0.11 |
| Weighted Avg Shares Outstanding | $28.13M | $27.13M | $26.94M | $25.80M |
| Weighted Avg Shares Outstanding (Diluted) | $28.13M | $27.13M | $26.94M | $25.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan